Emails Promoting COVID-19 Vaccination Among Healthcare Workers

Status Completed

Clinical Trial Summary

In this evaluation, two versions of emails will be sent to Geisinger employees who have not been vaccinated against COVID-19. A delayed-contact control group will be emailed after a delay of at least two days. The researchers hypothesize that either of the emails - which use content informed by behavioral nudge theory - will lead to more COVID-19 vaccinations than the delayed-contact control group.

Clinical Trial Description

The researchers aim to evaluate the effectiveness of email reminders in promoting COVID-19 vaccinations among Geisinger employees. The project will compare two emails, which will vary in the subject line and email content. Both emails will test different approaches that draw from principles in behavioral science: social proof, reframing, and scarcity. Employees receiving these emails will be compared with employees in a delayed-contact group, who will not receive emails. Employees in the control group will later receive one of the emails.The responses to the emails will help determine the communications later sent to the control group. All emails will ask recipients if they want to receive a COVID-19 vaccination. If they click on a hyperlink indicating yes, they will be forwarded to an online registration and scheduling homepage. If they click on a hyperlink indicating no, they will be forwarded to an online questionnaire surveying people about their main reason for declining the vaccine at this time. The questionnaire will automatically present information intended to assuage the specific concern that people endorse, followed by a hyperlink to the scheduling site. The data will be analyzed with logistic regression models with the control group as the reference group, to compare the two email conditions versus the control group. This set of analyses will only be conducted for scheduling a vaccination appointment as opposed to email engagement outcomes (e.g., number of emails opened), which will not be applicable for the control group. A second set of logistic regression models predicting scheduling a vaccination appointment and email engagement will also be run, comparing the two email conditions against each other. The data will be examined two days later (to help decide which email to send to the delayed-control group) and four days later (when the policy for employee vaccination will change, making the content of the email irrelevant). Update: The researchers looked at 3 days of data - as the emails to the delayed contact group were only sent at that time - and 4 days of data when the policy for employee vaccinations changed. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04728594
Study type	Interventional
Source	Geisinger Clinic
Contact
Status	Completed
Phase	N/A
Start date	January 15, 2021
Completion date	January 20, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05203146` - PIMPmyHospital: a Mobile App to Improve Emergency Care Efficiency and Communication	N/A
Completed	`NCT04105751` - Testing a Novel Manual Communication System for Mechanically Ventilated ICU Patients	N/A
Completed	`NCT04595695` - The Effect of Clear Masks in Improving Patient Relationships	N/A
Completed	`NCT05540444` - RadConnect Communication Application
Recruiting	`NCT04317664` - Intervention to Improve Driving Practices Among High-Risk Teen Drivers	Phase 3
Completed	`NCT05812599` - Understanding COVID-19 Testing Knowledge and Practices Among 2-1-1 Helpline Callers	N/A
Completed	`NCT03221985` - ESM Pilot: Mobile Phones and Psychology	N/A
Completed	`NCT02619474` - The Effect of Whiteboards on Patient Satisfaction	N/A
Completed	`NCT02267265` - Pilot Study of Novel Postpartum Educational Video Intervention	N/A
Completed	`NCT03203018` - Health Literacy and Cardiovascular Knowledge Workshop in Women From Disadvantaged Communities	N/A
Completed	`NCT02695316` - Barrier-free Communication in Maternity Care of Allophone Migrants	N/A
Completed	`NCT01933789` - Improving Communication About Serious Illness	N/A
Completed	`NCT01697137` - Patient and Physician Intervention to Increase Organ Donation	N/A
Completed	`NCT01459744` - An Intervention to Improve Implantable Cardioverter-Defibrillator Deactivation Conversations	N/A
Recruiting	`NCT01170000` - Timely End-of-Life Communication to Parents of Children With Brain Tumors	N/A
Completed	`NCT01040975` - Teen CHAT: Improving Physician Communication With Adolescents About Healthy Weight	N/A
Completed	`NCT03044145` - The Cultural Formulation Interview-Engagement Aid	N/A
Recruiting	`NCT04533126` - Channels of Communication & Brain Functioning: Pilot fMRI Study
Withdrawn	`NCT03901547` - Emotion Regulation and Burnout Impact on Communication Documentation	N/A
Completed	`NCT06081660` - Advance Care Planning for Older Latinos With Chronic Illness	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.